NNC6019-0001

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC6019-0001, covering 2025-11-25 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis [Phase 2]

See pricing